CT Financial Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $25.5K | Buy |
603
+1
| +0.2% | +$42 | 0.02% | 333 |
|
|
2016
Q4 | $23.4K | Buy |
602
+1
| +0.2% | +$39 | 0.01% | 337 |
|
|
2016
Q3 | $25.2K | Buy |
601
+1
| +0.2% | +$42 | 0.02% | 330 |
|
|
2016
Q2 | $22.2K | Sell |
600
-1
| -0.2% | -$37 | 0.01% | 340 |
|
|
2016
Q1 | $23K | Buy |
601
+1
| +0.2% | +$38 | 0.01% | 359 |
|
|
2015
Q4 | $30.3K | Buy |
600
+3
| +0.5% | +$152 | 0.02% | 341 |
|
|
2015
Q3 | $27.3K | Buy |
597
+2
| +0.3% | +$91 | 0.02% | 352 |
|
|
2015
Q2 | $34.7K | Buy |
595
+1
| +0.2% | +$58 | 0.02% | 340 |
|
|
2015
Q1 | $32.7K | Buy |
594
+1
| +0.2% | +$55 | 0.02% | 342 |
|
|
2014
Q4 | $29.8K | Buy |
+593
| New | +$29.8K | 0.02% | 285 |
|
|
2014
Q1 | $32.7K | Buy |
+594
| New | +$32.7K | 0.02% | 342 |
|